Showing results (2051-2060 of 2,140) with videos related to

Sort By:
Pageof 214
JAMA Network Open|September 22, 2025
Factors in the Initial Resuscitation of Patients With Severe Trauma: The FiiRST-2 Randomized Clinical TrialLuis T da Luz, Keyvan Karkouti, Jo Carroll, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Mbio|September 3, 2020
Unveiling Crucivirus Diversity by Mining Metagenomic DataIgnacio de la Higuera, George W Kasun, Ellis L Torrance, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2020
Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a TrialPy Iroh Tam, S L M Arnold, L K Barrett, et al.
Spine|March 12, 2004
Similarities and differences in the treatment of spine trauma between surgical specialties and location of practiceJonathan N Grauer, Alexander R Vaccaro, John M Beiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer ConsortiumPawadee Lohavanichbutr, Lori C Sakoda, Christopher I Amos, et al.
Ebiomedicine|July 25, 2025
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesotheliomaAaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
Research and Practice in Thrombosis and Haemostasis|August 4, 2023
Illustrated State-of-the-Art Capsules of the ISTH 2023 CongressSusan R Kahn, Donald M Arnold, Caterina Casari, et al.
Pageof 214